Providing stock analysis for investors of the Canadian junior markets
DiagnaMed Holdings (CSE: DMED) has launched its first commercial product under its initiative to bring artificial intelligence to the healthcare industry. The initiative is currently focused on using AI to improve patient outcomes, operational workflow, and efficiency within the industry.
Read more
Joining us today on the Daily Dive is that of DiagnaMed Holdings (CSE: DMED) Chairman Fabio Chianelli, and Dr. John
Read more
DiagnaMed Holdings (CSE: DMED) is moving to enhance its brain health artificial intelligence platform known as CERVAI. The company has
Read more
DiagnaMed Holdings (CSE: DMED) appears to be going all in on artificial intelligence. The drug development firm this morning revealed
Read more
DiagnaMed Holdings (CSE: DMED) is moving towards obtaining regulatory approval for its Brain Age clinical solution by the end of
Read more